| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA391615
Max Phase: Preclinical
Molecular Formula: C32H36F7N3O3
Molecular Weight: 643.64
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: CC(=O)N1CCC(C(=O)N2C[C@H](C(=O)N(C)C(C)(C)c3cc(C(F)(F)F)cc(C(F)(F)F)c3)[C@@H](c3ccc(F)cc3C)C2)CC1
Standard InChI: InChI=1S/C32H36F7N3O3/c1-18-12-24(33)6-7-25(18)26-16-42(28(44)20-8-10-41(11-9-20)19(2)43)17-27(26)29(45)40(5)30(3,4)21-13-22(31(34,35)36)15-23(14-21)32(37,38)39/h6-7,12-15,20,26-27H,8-11,16-17H2,1-5H3/t26-,27+/m1/s1
Standard InChI Key: QXYXAFHTANBIQX-SXOMAYOGSA-N
Associated Targets(Human)
TACR1 Tclin Neurokinin 1 receptor (6273 Activities)
CYP3A4 Tclin Cytochrome P450 3A4 (53859 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
CYP2D6 Tclin Cytochrome P450 2D6 (33882 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
CYP2C9 Tchem Cytochrome P450 2C9 (32119 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Associated Targets(non-human)
Gerbil, jird (129 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 643.64 | Molecular Weight (Monoisotopic): 643.2645 | AlogP: 6.37 | #Rotatable Bonds: 5 |
| Polar Surface Area: 60.93 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 0 |
| #RO5 Violations: 2 | HBA (Lipinski): 6 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 2 |
| CX Acidic pKa: | CX Basic pKa: | CX LogP: 4.89 | CX LogD: 4.89 |
| Aromatic Rings: 2 | Heavy Atoms: 45 | QED Weighted: 0.36 | Np Likeness Score: -0.92 |
References
| 1. Young JR, Eid R, Turner C, DeVita RJ, Kurtz MM, Tsao KL, Chicchi GG, Wheeldon A, Carlson E, Mills SG.. (2007) Pyrrolidine-carboxamides and oxadiazoles as potent hNK1 antagonists., 17 (19): [PMID:17723300] [10.1016/j.bmcl.2007.08.028] |
Source
Source(1):